Spermatogenic failure can result from mutations, polymorphisms, deletions, or other changes that affect one or more of the spermatogenesis-related genes, markers, or DNA sequences on the human Y chromosome, which can be investigated using a variety of different electrophoresis formats, such as heteroduplex analysis (dHPLC), single-strand conformation polymorphisms (SSCPs), denaturing gradient gel electrophoresis, or DNA sequencing.
Resolving the multiplex PCR products on conventional gels or other traditional separation methods may not be helpful, especially when DNA fragment lengths are close to each other. Microchip electrophoresis technology affords the solution in such problems by offering a robust, rapid, and highly reproducible system for separation with good resolution. [15] [16] [17] In this report, we present an example of using combined multiplex PCR and multichannel microchip electrophoresis analysis for diagnosis of microdeletions in three Y chromosome sequence-tagged sites (STS), DYS211, DYS252 and DYS241. We illustrate how the combination of both technologies provides a rapid, effective, reproducible, and robust resolution of all fragments including those with only 11-bp differences, in the DNA range of 190-250 bp.
MATERIALS AND METHODS
The Agilent 2100 Bioanalyzer microchip electrophoresis system (Agilent Technologies, Germany), which has epifluorescent detection with a semiconductor laser emitting at 630 nm was used. This Agilent chip is made from soda lime glass, has 12 sample wells with three gel-dye mix wells and one for the ladder. The depth of the channel is 10 mm, the width is 50 mm, and its effective separation length is 15 mm. Agilent microchip electrophoresis has been used for the separation of DYS252 (220 bp) and DYS241 (231 bp), (Fig. 1) .
The Hitachi SV 1210 Microchip electrophoresis system (Hitachi Electronics Co., Tokyo, Japan), has an LED detector (exciting wavelength at 470 nm, emission wavelength at 530 nm) and 12 channels each of which with a detecting point. Hitachi 12-lane microchips have been used for the separation of DYS211 (191 bp), DYS252 (220 bp), and DYS241 (231 bp), (Fig. 2) , when the injection voltage is 130 V, and the separation voltage is 750 V.
DNA samples were obtained from the Department of Human Genetics and Public Health, University of Tokushima School of Medicine, where blood samples from patients with infertility are being collected and analyzed in a research project that is approved by the Medical Ethical Committee of Tokushima University. PCR was performed on each marker separately to confirm the efficiency of all reagents and conditions. The multiplex PCR conditions were as follows: the denaturizing step was performed at 94°C for 1 min, followed by annealing at 56°C for 1 min and an extension step at 72°C for 1 min. The above conditions were repeated for 35 cycles. After completion of the cycles, a final extension step at 72°C for 10 min was performed and the final PCR product was stored at 4°C until electrophoresis.
RESULTS AND DISCUSSION
In the post genome era, efforts to find target genes for genomic research and the diagnosis of human genetic diseases for therapeutic purposes are necessary for the improvement of this important field for future medicine. Microchip electrophoresis as an ultrafast and reliable tool that can be utilized in screening assays for the diagnosis of presymptomatic disease states and detection of the underlying causes of non obstructive azoospermia and hypo spermatogenesis, i.e., spermatogenetic failure. [18] [19] [20] Approximately 20% of men who seek help at infertility clinics present with non obstructive oligo or azoospermia. Most of these men are chromosomally normal but may have microdeletions in the AZF regions of their Y chromosomes, which cause them to have low sperm counts or severe forms of spermatogenic failure.
In this study, three human Y chromosome STS related to human spermatogenetic failure were chosen for multiplex PCR amplification and on-chip detection. Those three STS are located on the Y chromosome and were mapped to the critical regions for male infertility AZF regions. The whole length of the DYS211 is 467 bp, that of DYS252 is 483 bp, and that of DYS241 is 368 bp. The markers are: DYS211 (also known as Sy119), DYS252 (also known as Sy19), and the DYS241 (also known as Sy158) with fragment lengths of 191, 220, and 231 bp, respectively ( Table 1) .
The theoretical T m value of these markers ranges from 50 to 54°C, although experimentally, the T m that could amplify each of the three DNA markers separately was detected at 56°C. Therefore we continued to use the 56°C for the annealing step as the optimum T m for the amplification of these STS in a multiplex PCR for all the patient DNA samples collected.
First, we performed multiplex PCR for the two markers DYS252 (220 bp) and DYS241 (231 bp) to confirm the possibility of amplifying and separating them since their PCR fragments lengths are very close. The amplification was achieved successfully at T m ϭ56°C and they were separated with an accepted resolution even with the narrow difference in size between them (11 bp) (Fig. 1) . Based on the previous successful results we added the third marker DYS211 (191 bp) to be amplified with the other two under the same amplification conditions. The separation of the three markers after amplification was also successful at T m ϭ56°C (Fig. 2b) .
Since the clinical application of DNA marker analysis is one of the final targets of genomic research, we searched for a clinical application of this multiplex PCR for the diagnosis of the presence or absence of Y chromosome microdeletions as an underlying cause of human male infertility. Thus we analyzed three Y chromosome STS with multiplex PCR on a 12-lane multichannel microchip, which has the analytical power to separate and analyze 12 mixtures of DNA samples simultaneously within only 180 s. with the combination of multiplex PCR with multichannel microchip electrophoresis, 36 DNA markers (3ϫ12ϭ36) were analyzed within only 180 s (Fig. 2) . We conclude that this new method presents a powerful tool for ultrafast and reliable analysis of genetic markers that can be used in screening for the diagnosis of genetic diseases.
CONCLUSION
These results show the importance of combing microchip electrophoresis with other techniques such as multiplex PCR for the diagnosis of genetic diseases. This expands the use of microchip electrophoresis as a separation tool with ultrafast separation power (36 DNA markers in 180 s), with a small sample volume consumed for the clinical and medical genetics. 
